Tag - medicine-4

 
 

MEDICINE 4

Japan Times
COMMENTARY / World
Oct 26, 2022
Let’s make sure lab-grown viruses stay in the lab
Boston University researchers created a new strain of COVID-19. Such work is important, but needs more stringent oversight.
Japan Times
WORLD
Oct 26, 2022
New COVID boosters aren’t better than old ones, small study finds
The early results don't mean that getting a bivalent shot has no benefit, but they do raise the question of whether the switch to a new version of the vaccine was necessary.
Japan Times
WORLD / Science & Health
Oct 25, 2022
Lab manipulations of COVID virus fall under murky government rules
Mouse experiments at Boston University have spotlighted an ambiguous U.S. policy for research on potentially dangerous pathogens.
Japan Times
COMMUNITY / How-tos
Oct 25, 2022
Booked, cooked and shook: My experience getting LASIK in Japan
Writer Kat Joplin provides a first-hand account of getting LASIK at a medical center in Japan, and reveals whether it was worth it in the end.
Japan Times
COMMENTARY
Oct 24, 2022
New COVID-19 variants have arrived. How worried should you be?
Fearmongering headlines on the new COVID-19 variants are misleading and counter the message on the effectiveness of vaccines.
Japan Times
WORLD / Science & Health
Oct 18, 2022
High hopes for nasal COVID-19 vaccines despite 'disappointing' trial
By entering the body the same way as the virus, nasal vaccines aim to build immunity in the mucous membrane that line the nose and mouth.
Japan Times
WORLD / Science & Health
Oct 14, 2022
Scientists find gene variant tied to better COVID shot response
Scientists have identified an immunity gene variant in people with strong responses to COVID-19 vaccines who were less likely to get breakthrough infections.
Japan Times
JAPAN
Oct 13, 2022
Japan updates advice on clinic visits for COVID patients amid 'twindemic' fears
People between the ages of 12 and 64 with a low risk of developing severe COVID-19 symptoms have been asked to refrain from going to so-called fever clinics.
Japan Times
COMMENTARY / World
Oct 12, 2022
Don’t cancel your colonoscopy just yet
Data from a large trial on colonoscopies appears to cast doubt over the benefits of the colon cancer screen. But it's a lot more complicated.
Japan Times
WORLD
Oct 10, 2022
Screening procedure fails to prevent colon cancer deaths in large study
While people who underwent the exam were 18% less likely to develop colon cancer, the overall death rate among screened and unscreened people were the same at about 0.3%.
Japan Times
JAPAN / FOCUS
Oct 7, 2022
What did Japan learn from its largest and deadliest COVID wave?
While the surge of infections — fueled by the BA.5 subvariant of the omicron variant — has subsided, some important questions remain unanswered.
Japan Times
WORLD
Oct 5, 2022
Nursing shortage sparks bidding war as countries vie for talent
No nation is better prepared to help the world staff up its hospitals and clinics than the Philippines, the single biggest exporter of nurses.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
WORLD / Science & Health
Oct 4, 2022
Nobel Prize shines light on paleogenetics, the study of ancient DNA
New Nobel laureate Svante Paabo is considered the father of both paleogenetics and paleogenomics, which aims to reconstruct the genetic information of long extinct human relatives.
Japan Times
WORLD / Science & Health
Oct 3, 2022
Sweden's Svante Paabo wins 2022 Nobel Prize in medicine
Paabo won “for his discoveries concerning the genomes of extinct hominins and human evolution,' kicking off a week of winner announcements.
Japan Times
WORLD
Oct 3, 2022
Medicine prize opens Nobel week clouded by war
Breast cancer discoveries and mRNA vaccines are potential winners when the Nobel Prize in physiology or medicine kicks off a week of announcements held under the shadow of war in Europe.
Japan Times
JAPAN / Science & Health
Oct 2, 2022
Kowa says ivermectin not effective in treating COVID-19
The Nagoya-based company announced the results of its clinical trial, indicating it would no longer seek the drug's approval for COVID-19 treatment.
Japan Times
WORLD / Science & Health
Oct 1, 2022
New infectious threats are coming. The U.S. probably won’t contain them.
The coronavirus revealed flaws in the nation's pandemic plans. The spread of monkeypox shows that the problems remain deeply entrenched.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?